How much ABBV stock is too much?

There is no single threshold, but the larger the share of your net worth in one stock, the more a single bad year can set back your plans. The calculator above quantifies the drawdown impact at 30, 50, and 70 percent for your ABBV position and weighs selling down (which triggers capital-gains tax now) against hedging (which costs option premium).

Does AbbVie grant ISOs, NSOs, or RSUs?

Equity compensation at AbbVie typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.

Do AbbVie RSUs use double-trigger vesting?

No. AbbVie restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.

AbbVie (ABBV) Stock Concentration Calculator

Calculator · free · no signup · ABBV

Quantify AbbVie concentration risk. Drawdown impact at 30 / 50 / 70%, with the tax-aware trade-off between selling down and hedging.

Beta · invite-only · AlphaLatitude Inc. · Free Tools

Your inputs

Adjust — results update instantly.

Position & portfolio

Position value

Portfolio value

Cost basis

Acquisition date

Sector

Annual growthDefault. Adjust to test.

35%

Volatility dragDefault. Adjust to test.

20%

Market return / yr

10%

Tax

State

Annual income

Filing status

67%

Highly concentratedLong-term

If 30% drop

−$150,000

If 50% drop

−$250,000

If 70% drop

−$350,000

Most fee-only advisors target ≤10% in any single name. You're at 67%.

Estimates only. Not financial advice.

Most sensitive to: Expected market return (±10% on this input swings best-plan wealth by ±$190,508).

Cost of fully de-concentrating

All three plans sell to 0% (no hedge).

Tax

Wealth (3y)$956,485

+$33,417 vs.

Tax

Wealth (3y)$994,174

+$71,106 vs.

Tax

Wealth (3y)$1.04M

+$112,490 vs.

Sensitivity. If your expected position return drops below 19.6%/yr, lump-sum (sell everything today) beats every spread plan above.

Have multiple RSU vest lots? The RSU Lot Order Calculator picks which lots to sell first, and on which dates, to divest at the lowest computed tax.

Design a hedge →

Build your own plan

Toggle below — chart updates live. Sell buttons show the slice.

Sell over 1 yearSell over 2 yearsSell over 3 yearsCustom

Year 1

Year 2

Year 3

Tax$200,753

Hedge cost$37,676

Wealth at Y3$1,046,371

Vs. best fixed plan+$10,813

Tech / Software single names hit a 50%+ peak-to-trough drawdown in roughly 1 of every 5 rolling 3-year windows over 2014–2024. Even mega-caps aren’t exempt.

Tax brackets: 2026 · Estimates only — not financial advice.

Estate note. Heirs receive a stepped-up basis at death (§1014), eliminating built-in gain on inherited shares. Older holders who plan to bequeath rather than sell may rationally never de-concentrate.

You sized one position's risk. The beta integrates hedging, sell-down, and tax timing into one optimized plan.

Request beta access →

About AbbVie

AbbVie (ABBV) is a public Other company, incorporated in Delaware and headquartered in North Chicago, IL.

Equity grants at AbbVie typically include restricted stock units (RSUs).

AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.

Source: Wikipedia (CC BY-SA 4.0)

Abbott Laboratories separated its research-based pharmaceutical business in 2013, and the new company carried Humira, which became the best-selling drug in the world and supplied most of its profit. Preparing for that patent cliff drove the $63 billion Allergan acquisition in 2020, adding Botox and eye care, plus the immunology successors Skyrizi and Rinvoq, which have largely replaced Humira revenue after United States biosimilars arrived in 2023. Headquarters are in North Chicago, Illinois.

Sources: abbvie.com · en.wikipedia.org

Equity comp at AbbVie

RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.

Researched 2026-08-17.

OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by AbbVie.

If a meaningful share of your net worth sits in ABBV, concentration risk is the question. This calculator quantifies drawdown impact at 30 / 50 / 70%, and the trade-off between selling down (tax cost now) versus hedging (option premium drag), auto-filled with ABBV's option-implied volatility.

All AbbVie tools → · Use the generic Stock Concentration Calculator for any company. Diversifying multiple RSU lots? See the lot-by-lot sell order →

AbbVie equity questions

How much ABBV stock is too much?: There is no single threshold, but the larger the share of your net worth in one stock, the more a single bad year can set back your plans. The calculator above quantifies the drawdown impact at 30, 50, and 70 percent for your ABBV position and weighs selling down (which triggers capital-gains tax now) against hedging (which costs option premium).
Does AbbVie grant ISOs, NSOs, or RSUs?: Equity compensation at AbbVie typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
Do AbbVie RSUs use double-trigger vesting?: No. AbbVie restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.

Find another companyOther peers

RiverNorth Long Prime Unicorn Fund I, Inc.PublicOpen →
RiverNorth Short Prime Unicorn Fund I, IncPublicOpen →
Global X FundsPublicOpen →
Accenture (ACN)PublicOpen →
Cognizant (CTSH)PublicOpen →
Globant (GLOB)PublicOpen →
DXC Technology (DXC)PublicOpen →
Eli Lilly (LLY)PublicOpen →
Pfizer (PFE)PublicOpen →
Merck (MRK)PublicOpen →

One piece of the puzzle.

OptionsAhoy plans your AbbVie equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.

Request beta access